EE524 Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in Costa Rica

Saved in:
Bibliographic Details
Published in:Value in health 2023-12, Vol.26 (12), p.S152
Main Authors: Rendon, A.M., Cordoba, R., Wurcel, V., Rubino, R., Junqueira, M., Haiderali, A., Huang, M., Khandelwal, A., Gotarkar, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2023.09.789